Monday, August 6, 2012

Johnson & Johnson fined $2.2 Billion

WSJ-7/20/12 - Federal prosecutors reached a settlement with drug company Johnson and Johnson of $2.2 billion that includes a $400 million criminal fine for illegal marketing of the drug Risperdal.. Under
federal law, drug companies can only market drugs approved by the U. S. Food and Drug Administration. The Journal article stated many companies settle investigations into illegal marketing of drugs to avoid losing the ability to sell drugs to government health programs and Medicare.
    *    *    *    *

No comments:

Post a Comment